Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

gadofosveset trisodium

The trisodium salt form of gadofosveset, an injectable, intravascular, amphiphilic gadolinium-based contrast agent (GBCA) used with magnetic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
OBJECTIVE The purpose of this review is to illustrate various applications of gadofosveset trisodium in evaluating abdominal and… 
2012
2012
PURPOSE In this study, image quality of leg veins and vena cava inferior was scored by independent raters using the new… 
2012
2012
Endometriosis is defined as the presence of endometrial tissue outside the uterus. It affects 10–15% of women during reproductive… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2010
2010
OBJECTIVE This prospective multicenter intraindividual crossover study was designed to compare gadobenate dimeglumine and… 
  • table 1
  • figure 1—62
  • table 4
  • figure 2—73
2009
2009
To compare a high‐resolution, ECG‐gated, motion‐compensated, steady‐state magnetic resonance angiography (SS‐MRA) of the thoracic… 
Highly Cited
2007
Highly Cited
2007
Objectives:To evaluate gadofosveset trisodium for first-pass magnetic resonance angiography (MRA) in the setting of whole-body… 
2006
2006
Objectives:Vasovist (EPIX Pharmaceuticals and Schering AG) is a newly developed blood pool contrast agent for magnetic resonance… 
Review
2006
Review
2006
The purpose of this study was to prospectively evaluate the diagnostic accuracy of reader detection of 75% or greater stenosis at… 
Review
2005
Review
2005
PURPOSE To evaluate prospectively the safety and effectiveness of aortoiliac magnetic resonance (MR) angiography enhanced with MS… 
Highly Cited
2003
Highly Cited
2003
PURPOSE To evaluate the dose response and safety of gadofosveset trisodium-enhanced magnetic resonance (MR) angiography compared…